NCIt definition : A humanized immunoglobulin G1 (IgG1) monoclonal antibody directed against interleukin-5
(IL-5) with anti-asthmatic and potential immunosuppressive activity. Upon subcutaneous
administration, mepolizumab selectively binds to IL-5, preventing it from associating
with interleukin-5 receptor subunit alpha (IL5RA) on the surface of eosinophils and
their progenitors. IL-5 plays a role in the regulation of eosinophil development from
hematopoietic progenitors as well as eosinophil maturation, differentiation, mobilization,
activation, and survival. IL-5 also play a role in the pathogenesis of some phenotypes
of hypereosinophilic syndrome (HES).;
--- https://www.has-sante.fr/jcms/p_3473151/fr/dupixent-fasenra-nucala-tezspire-et-xolair-dans-le-traitement-de-l-asthme-severe 2023 France guidelines for drug use No Treatment for Diabetes Nucala Omalizumab Borg Category-Ratio 10 Perceived Exertion Score 5 Omalizumab Treat tezspire Treatment Treatment Study Severe Hallucination Intensity and Distress 5 Severe Adverse Event During Treatment Epidermal cGVHD Score 4 Asthma Dupilumab asthma Fasenra Asthma Pathway xolair severe Severe Dysplasia asthma, nos On Treatment GDC Treatment Frequency Terminology Treatment Epoch Therapy Object Dupixent asthma Biomaterial Treatment Severe Extremity Pain Mepolizumab